Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F

NCT04238689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Malaria,Falciparum

Interventions

BIOLOGICAL: TB31F

Sponsor

Radboud University Medical Center

Collaborators

[object Object]